Caseware UK (AP4) 2024.0.164 2024.0.164 2025-07-312025-07-3163172024-08-01truefalsefalsetrueNo description of principal activity3132 SC364707 2024-08-01 2025-07-31 SC364707 2023-08-01 2024-07-31 SC364707 2025-07-31 SC364707 2024-07-31 SC364707 2023-08-01 SC364707 c:Director2 2024-08-01 2025-07-31 SC364707 d:Buildings 2024-08-01 2025-07-31 SC364707 d:Buildings d:LongLeaseholdAssets 2024-08-01 2025-07-31 SC364707 d:Buildings d:LongLeaseholdAssets 2025-07-31 SC364707 d:Buildings d:LongLeaseholdAssets 2024-07-31 SC364707 d:PlantMachinery 2024-08-01 2025-07-31 SC364707 d:PlantMachinery 2025-07-31 SC364707 d:PlantMachinery 2024-07-31 SC364707 d:PlantMachinery d:OwnedOrFreeholdAssets 2024-08-01 2025-07-31 SC364707 d:PlantMachinery d:LeasedAssetsHeldAsLessee 2024-08-01 2025-07-31 SC364707 d:MotorVehicles 2024-08-01 2025-07-31 SC364707 d:MotorVehicles 2025-07-31 SC364707 d:MotorVehicles 2024-07-31 SC364707 d:MotorVehicles d:OwnedOrFreeholdAssets 2024-08-01 2025-07-31 SC364707 d:MotorVehicles d:LeasedAssetsHeldAsLessee 2024-08-01 2025-07-31 SC364707 d:FurnitureFittings 2024-08-01 2025-07-31 SC364707 d:FurnitureFittings 2025-07-31 SC364707 d:FurnitureFittings 2024-07-31 SC364707 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-08-01 2025-07-31 SC364707 d:FurnitureFittings d:LeasedAssetsHeldAsLessee 2024-08-01 2025-07-31 SC364707 d:OfficeEquipment 2024-08-01 2025-07-31 SC364707 d:OfficeEquipment 2025-07-31 SC364707 d:OfficeEquipment 2024-07-31 SC364707 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-08-01 2025-07-31 SC364707 d:OfficeEquipment d:LeasedAssetsHeldAsLessee 2024-08-01 2025-07-31 SC364707 d:OtherPropertyPlantEquipment 2024-08-01 2025-07-31 SC364707 d:OtherPropertyPlantEquipment 2025-07-31 SC364707 d:OtherPropertyPlantEquipment 2024-07-31 SC364707 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2024-08-01 2025-07-31 SC364707 d:OtherPropertyPlantEquipment d:LeasedAssetsHeldAsLessee 2024-08-01 2025-07-31 SC364707 d:OwnedOrFreeholdAssets 2024-08-01 2025-07-31 SC364707 d:LeasedAssetsHeldAsLessee 2024-08-01 2025-07-31 SC364707 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-07-31 SC364707 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-07-31 SC364707 d:Goodwill 2024-08-01 2025-07-31 SC364707 d:Goodwill 2025-07-31 SC364707 d:Goodwill 2024-07-31 SC364707 d:CurrentFinancialInstruments 2025-07-31 SC364707 d:CurrentFinancialInstruments 2024-07-31 SC364707 d:Non-currentFinancialInstruments 2025-07-31 SC364707 d:Non-currentFinancialInstruments 2024-07-31 SC364707 d:CurrentFinancialInstruments d:WithinOneYear 2025-07-31 SC364707 d:CurrentFinancialInstruments d:WithinOneYear 2024-07-31 SC364707 d:Non-currentFinancialInstruments d:AfterOneYear 2025-07-31 SC364707 d:Non-currentFinancialInstruments d:AfterOneYear 2024-07-31 SC364707 d:ShareCapital 2025-07-31 SC364707 d:ShareCapital 2024-07-31 SC364707 d:RetainedEarningsAccumulatedLosses 2024-08-01 2025-07-31 SC364707 d:RetainedEarningsAccumulatedLosses 2025-07-31 SC364707 d:RetainedEarningsAccumulatedLosses 2024-07-31 SC364707 d:AcceleratedTaxDepreciationDeferredTax 2025-07-31 SC364707 d:AcceleratedTaxDepreciationDeferredTax 2024-07-31 SC364707 d:TaxLossesCarry-forwardsDeferredTax 2025-07-31 SC364707 d:TaxLossesCarry-forwardsDeferredTax 2024-07-31 SC364707 d:OtherDeferredTax 2025-07-31 SC364707 d:OtherDeferredTax 2024-07-31 SC364707 c:OrdinaryShareClass1 2024-08-01 2025-07-31 SC364707 c:OrdinaryShareClass1 2025-07-31 SC364707 c:OrdinaryShareClass1 2024-07-31 SC364707 c:FRS102 2024-08-01 2025-07-31 SC364707 c:Audited 2024-08-01 2025-07-31 SC364707 c:FullAccounts 2024-08-01 2025-07-31 SC364707 c:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 SC364707 c:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 SC364707 2 2024-08-01 2025-07-31 SC364707 6 2024-08-01 2025-07-31 SC364707 d:PlantMachinery d:LeasedAssetsHeldAsLessee 2025-07-31 SC364707 d:PlantMachinery d:LeasedAssetsHeldAsLessee 2024-07-31 SC364707 d:MotorVehicles d:LeasedAssetsHeldAsLessee 2025-07-31 SC364707 d:MotorVehicles d:LeasedAssetsHeldAsLessee 2024-07-31 SC364707 d:LeasedAssetsHeldAsLessee 2025-07-31 SC364707 d:LeasedAssetsHeldAsLessee 2024-07-31 SC364707 d:Goodwill d:OwnedIntangibleAssets 2024-08-01 2025-07-31 SC364707 d:DevelopmentCostsCapitalisedDevelopmentExpenditure d:OwnedIntangibleAssets 2024-08-01 2025-07-31 SC364707 e:PoundSterling 2024-08-01 2025-07-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration Number:  SC364707



















ECO-GENICS LTD
FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR
 31 JULY 2025













img5092.png

 
ECO-GENICS LTD
REGISTERED NUMBER: SC364707

STATEMENT OF FINANCIAL POSITION
AS AT 31 JULY 2025

2025
2024
Note
£
£

Fixed assets
  

Intangible assets
 4 
65,466
69,464

Tangible assets
 5 
768,719
862,395

Investments
 6 
888,375
888,375

  
1,722,560
1,820,234

Current assets
  

Stocks
  
83,992
19,976

Debtors: amounts falling due within one year
 7 
1,701,532
1,372,328

Cash at bank and in hand
  
103,238
3,295

  
1,888,762
1,395,599

Creditors: amounts falling due within one year
 8 
(2,195,405)
(1,961,429)

Net current liabilities
  
 
 
(306,643)
 
 
(565,830)

Total assets less current liabilities
  
1,415,917
1,254,404

Creditors: amounts falling due after more than one year
 9 
(296,512)
(366,915)

Provisions for liabilities
  

Deferred tax
 10 
(121,305)
(74,460)

  
 
 
(121,305)
 
 
(74,460)

Net assets
  
998,100
813,029

Page 1

 
ECO-GENICS LTD
REGISTERED NUMBER: SC364707

STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 JULY 2025

2025
2024
Note
£
£

Capital and reserves
  

Called up share capital 
 11 
2
2

Profit and loss account
 12 
998,098
813,027

  
998,100
813,029


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Ms D Daly
Director

Date: 20 February 2026

The notes on pages 3 to 14 form part of these financial statements.

Page 2

 
ECO-GENICS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

1.


General information

Eco-Genics Ltd is a private company limited by shares incorporated in Scotland. The company registered number is SC364707. The registered office address and principal place of business is 6 Annan Business Park Way, Annan, Dumfries and Galloway, DG12 6TZ.

The financial statements have been presented in Pounds Sterling, and this is the functional currency of the company.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the requirements and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

  
2.2

Going concern

In assessing the company’s ability to continue as a going concern, the directors have considered the financial performance for the year, including the profitable results reported, together with the company’s cash position and available financing facilities. The directors have also reviewed detailed forecasts covering a period of at least 12 months from the date of approval of these financial statements. These forecasts demonstrate that the company is expected to generate sufficient resources to meet its liabilities as they fall due.

After consideration of all factors, the directors continue to adopt the going concern basis in preparing
the financial statements.

Page 3

 
ECO-GENICS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

2.Accounting policies (continued)

 
2.3

Revenue

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Sale of goods

Turnover from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of turnover can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of turnover can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
2.5

Leased assets: the Company as lessee

Assets obtained under hire purchase contracts and finance leases are capitalised as tangible fixed assets. Assets acquired by finance lease are depreciated over the shorter of the lease term and their useful lives. Assets acquired by hire purchase are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to profit or loss so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.

 
2.6

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 4

 
ECO-GENICS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

2.Accounting policies (continued)

 
2.7

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.8

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.9

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.10

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


Page 5

 
ECO-GENICS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

2.Accounting policies (continued)

 
2.11

Intangible assets

Goodwill

Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight-line basis to the Statement of income and retained earnings over its useful economic life.

 The estimated useful lives range as follows:

Goodwill
-
10
years

 
2.12

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, as follows:.

Depreciation is provided on the following basis:

Leasehold improvements
-
20%
straight line
Plant and machinery
-
15%
reducing balance/10% straight line
Motor vehicles
-
25%
reducing balance
Fixtures and fittings
-
15%
reducing balance
Office equipment
-
25%
straight line
-

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

  
2.13

Revaluation of tangible fixed assets

Specialist plant and machinery assets are carried at current year value at fair value at the date of the revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. Revaluations are undertaken with sufficient regularity to ensure the carrying amount does not differ materially from that which would be determined using fair value at the reporting date.

Fair values are determined from market based evidence normally undertaken by professionally qualified valuers.

Revaluation gains and losses are recognised in other comprehensive income unless losses exceed the previously recognised gains or reflect a clear consumption of economic benefits, in which case the excess losses are recognised in profit or loss.

Page 6

 
ECO-GENICS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

2.Accounting policies (continued)

 
2.14

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each reporting date. Gains and losses on remeasurement are recognised in the Statement of comprehensive income for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

  
2.15

Development costs

The Company recognises an intangible asset in respect of development expenditure when it can demonstrate:
- its technical feasibility of completing the intangible asset so that it will be available for use or sale;
- its intention to complete the intangible asset and use or sell it;
- its ability to use or sell the intangible asset;
- how the intangible asset will generate probable future economic benefits. Among other things, the
 Company can demonstrate the existence of a market for the output of the intangible asset or the
 intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset;
- the availability of adequate technical, financial and other resources to complete the development
 and to use or sell the intangible asset; and
- its ability to measure reliably the expenditure attributable to the intangible asset during its
 development.

Amortisation of capitalised development expenditure does not commence until the asset is available for use. All expenditure not meeting the criteria set out above is considered to form part of the 'research' phase, and is expensed in the period in which it is incurred.

 
2.16

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. 

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.17

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.18

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.19

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 7

 
ECO-GENICS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

2.Accounting policies (continued)

 
2.20

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.

Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.


3.


Employees

The average monthly number of employees, including directors, during the year was 31 (2024 - 32).


4.


Intangible assets




Development expenditure
Goodwill
Total

£
£
£



Cost


At 1 August 2024
80,212
15,000
95,212



At 31 July 2025

80,212
15,000
95,212



Amortisation


At 1 August 2024
21,749
4,000
25,749


Charge for the year on owned assets
2,497
1,500
3,997



At 31 July 2025

24,246
5,500
29,746



Net book value



At 31 July 2025
55,966
9,500
65,466



At 31 July 2024
58,463
11,000
69,463



Page 8

 
ECO-GENICS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

5.


Tangible fixed assets


Leasehold improvements
Plant and machinery
Motor vehicles
Fixtures and fittings

£
£
£
£



Cost or valuation


At 1 August 2024
26,848
525,161
411,732
35,810


Additions
-
11,476
-
8,894


Disposals
-
(9,850)
-
-



At 31 July 2025

26,848
526,787
411,732
44,704



Depreciation


At 1 August 2024
12,634
366,611
163,481
11,562


Charge for the year on owned assets
6,317
19,233
5,458
4,694


Charge for the year on financed assets
-
10,036
56,604
-


Disposals
-
(4,837)
-
-



At 31 July 2025

18,951
391,043
225,543
16,256



Net book value



At 31 July 2025
7,897
135,744
186,189
28,448



At 31 July 2024
14,214
158,550
248,251
24,248
Page 9

 
ECO-GENICS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

           5.Tangible fixed assets (continued)


Office equipment
Specialist P&M
Total

£
£
£



Cost or valuation


At 1 August 2024
43,484
400,000
1,443,035


Additions
2,045
-
22,415


Disposals
-
-
(9,850)



At 31 July 2025

45,529
400,000
1,455,600



Depreciation


At 1 August 2024
26,352
-
580,640


Charge for the year on owned assets
8,736
-
44,438


Charge for the year on financed assets
-
-
66,640


Disposals
-
-
(4,837)



At 31 July 2025

35,088
-
686,881



Net book value



At 31 July 2025
10,441
400,000
768,719



At 31 July 2024
17,132
400,000
862,395

The net book value of assets held under finance leases or hire purchase contracts, included above, are as follows:


2025
2024
£
£



Plant and machinery
25,781
30,331

Motor vehicles
169,813
226,418

195,594
256,749

Page 10

 
ECO-GENICS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

6.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 August 2024
888,375



At 31 July 2025
888,375





7.


Debtors

2025
2024
£
£


Trade debtors
482,869
390,105

Amounts owed by group undertakings
471,167
631,839

Other debtors
684,870
106,256

Prepayments and accrued income
62,626
244,128

1,701,532
1,372,328


Page 11

 
ECO-GENICS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

8.


Creditors: Amounts falling due within one year

2025
2024
£
£

Bank overdrafts
17,784
33,217

Bank loans
173,009
112,333

Trade creditors
97,839
226,086

Amounts owed to group undertakings
818,992
669,125

Corporation tax
1,644
1,644

Other taxation and social security
164,908
167,886

Obligations under finance lease and hire purchase contracts
98,731
88,060

Other creditors
808,748
645,583

Accruals and deferred income
13,750
17,495

2,195,405
1,961,429


Bank loans and overdraft are secured by a floating charge over the assets and undertakings of Eco-Genics Limited.

Obligations under finance lease and hire purchase contracts are secured on the assets to which they relate.

Included in other creditors is an invoice factoring account which is secured on the trade debtors of the company.


9.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Bank loans
183,245
154,917

Net obligations under finance leases and hire purchase contracts
113,267
211,998

296,512
366,915


Bank loans are secured by way of a floating charge over the assets of the company.

Obligations under finance lease and hire purchase contracts are secured on the assets to which they relate.

Page 12

 
ECO-GENICS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

10.


Deferred taxation




2025
2024


£

£






At beginning of year
(74,460)
(122,891)


Charged to profit or loss
(46,845)
48,431



At end of year
(121,305)
(74,460)

The provision for deferred taxation is made up as follows:

2025
2024
£
£


Accelerated capital allowances
122,212
135,860

Tax losses carried forward
(907)
(334)

Short term timing differences
-
(61,066)

121,305
74,460


11.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



2 (2024 - 2) Ordinary shares of £1.00 each
2
2



12.


Reserves

Profit and loss account

This reserve comprises of accumulated distributable profits and losses.


13.


Pension commitments

The pension cost charge represents contributions payable by the company to the fund and amounted to £15,788 (2024 - £15,011). Contributions totalling £3,628 (2024 - £3,120) were payable to the fund at the reporting date.


14.Commitments under operating leases

At 31 July 2025 the company had future minimum lease payments under non-cancellable operating leases of £9,694 (2024 -  £Nil). 

Page 13

 
ECO-GENICS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

15.


Related party transactions

The company has taken the s33.1A exemptions not to disclose transactions with its subsidiary, parent company or fellow wholly owned subsidiaries.


16.


Controlling party

This company's parent undertaking is Eco-Genics (Holdings) Ltd, a company registered in Scotland, company number SC482952. Its registered office address is 6 Annan Business Park, Annan, Dumfries and Galloway, Scotland, DG12 6TZ.

The consolidated accounts of Eco-Genics (Holdings) Ltd, which include Eco-Genics Limited, are available to the public and may be obtained from the Registrar of Companies, Companies House, Crown Way, Cardiff, CF14 3UZ

The company was under the control of Mr & Mrs Black throughout the current and prior period.



17.


Auditors' information

The auditors' report on the financial statements for the year ended 31 July 2025 was unqualified.

The audit report was signed on 20 February 2026 by Joanna Gray (Senior statutory auditor) on behalf of Armstrong Watson Audit Limited.


Page 14